IQV Dec 2024 240.000 call
| Previous Close | 16.60 |
| Open | 16.20 |
| Bid | 17.10 |
| Ask | 19.50 |
| Strike | 240.00 |
| Expire Date | 2024-12-20 |
| Day's Range | 16.20 - 16.60 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 75 |
- Business Wire
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
RESEARCH TRIANGLE PARK, N.C., May 14, 2024--Overall spending in the U.S. market for medicines grew by 2.5% and reached $435Bn in 2023. Excluding the contribution from COVID-19 vaccines and therapeutics, spending grew at 9.9%, according to a new report from the IQVIATM Institute for Human Data Science, The Use of Medicines in the U.S. 2024: Usage and Spending Trends and Outlook to 2028.
Simply Wall St.At US$234, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?
Let's talk about the popular IQVIA Holdings Inc. ( NYSE:IQV ). The company's shares saw a double-digit share price rise...
- Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 09, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT).
